Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 15/20 | 0.55 |
| ▸ | PLAT | P00750 | 1/20 | 0.42 |
| ▸ | TACR2 | P21452 | 1/20 | 0.41 |
| ▸ | TACR3 | P29371 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8936928 | 0.71 | TACR1 (1.00) | TACR1 | |
| SCHEMBL8936904 | 0.71 | TACR1 (0.63) | TACR1TACR2TACR3 | |
| SCHEMBL8936907 | 0.69 | TACR1 (0.64) | TACR1TACR2TACR3 | |
| SCHEMBL8936850 | 0.69 | TACR1 (0.80) | TACR1 | |
| SCHEMBL8936927 | 0.69 | TACR1 (0.80) | TACR1 | |
| SCHEMBL8936838 | 0.69 | TACR1 (0.80) | TACR1 | |
| SCHEMBL30788473 | 0.68 | SOD1 (0.56) | — | |
| SCHEMBL29125895 | 0.68 | SOD1 (0.56) | — | |
| Oxalic Acid SCHEMBL8936881 | 0.68 | TACR1 (0.93) | TACR1 | |
| SCHEMBL29126002 | 0.67 | SOD1 (0.56) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0858444-A4 | CYCLOPENTYL TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1999-12-01 | — | — | EP | disclosed |
| EP-0858444-A1 | CYCLOPENTYL TACHYKININ RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 1998-08-19 | — | — | EP | disclosed |
| WO-1997014671-A1 | CYCLOPENTYL TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | disclosed |